Pramlintide as an adjunct to insulin therapy improved glycemic and weight control in people with type 1 diabetes during treatment for 52 weeks

被引：0
|
作者：
Gottlieb, A
Velte, M
Fineman, M
Kolterman, O
机构：
来源：
DIABETES | 2000年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
439
引用
收藏
页码：A109 / A109
页数：1
相关论文
共 50 条
  • [41] Effect of Metformin as adjunct therapy with insulin in adolescent Pakistani people with type 1 diabetes
    Raza, Amina
    Ahmed, Iftikhar
    Fawwad, Asher
    Fatima, Fasiha
    Nangrejo, Ruqaya
    Soban, Madiha
    [J]. PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2023, 36 (04) : 1085 - 1088
  • [42] Switching to insulin detemir improves glycemic control and significantly reduces hypoglycemia over 52 weeks in french subjects with type 1 diabetes
    Hanaire, Helene
    Marre, Michel
    Laroche, Sylvie
    Ackermann, Ralf W.
    [J]. DIABETES, 2008, 57 : A591 - A592
  • [43] GLP-1 for six weeks reduces weight and improves insulin sensitivity and glycemic control in patients with type 2 diabetes
    Zander, M
    Madsbad, S
    Holst, JJ
    [J]. DIABETES, 2001, 50 : A31 - A31
  • [44] Dapagliflozin as an adjunct therapy to insulin in the treatment of patients with type 1 diabetes mellitus
    Tamez, Hector E.
    Tamez, Alejandra L.
    Garza, Lucas A.
    Hernandez, Mayra I.
    Polanco, Ana C.
    [J]. JOURNAL OF DIABETES AND METABOLIC DISORDERS, 2015, 14
  • [45] Dapagliflozin as an adjunct therapy to insulin in the treatment of patients with type 1 diabetes mellitus
    Hector E. Tamez
    Alejandra L. Tamez
    Lucas A. Garza
    Mayra I. Hernandez
    Ana C. Polanco
    [J]. Journal of Diabetes & Metabolic Disorders, 14 (1):
  • [46] Diabetes Distress and Its Association with Clinical Outcomes in Patients with Type 2 Diabetes Treated with Pramlintide as an Adjunct to Insulin Therapy
    Peyrot, Mark
    Rubin, Richard R.
    Polonsky, William H.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2008, 10 (06) : 461 - 466
  • [47] Improved glycemic control in type 1 diabetes via constitutive hepatic production of insulin
    Dong, HJ
    McEvoy, R
    Meseck, M
    Woo, SLC
    [J]. DIABETES, 2000, 49 : A9 - A9
  • [48] Pramlintide treatment for 4 weeks reduced glucose fluctuations in patients with type 1 diabetes intensively treated with insulin pumps
    Levetan, C
    Want, L
    Weyer, C
    Crean, J
    Strobel, S
    Wang, Y
    Maggs, D
    Schoenamsgruber, E
    Kolterman, O
    Chandran, M
    Mudalier, S
    Henry, R
    [J]. DIABETOLOGIA, 2002, 45 : A240 - A240
  • [49] Improved glycemic weight control without gain using triple therapy in type 2 diabetes
    Strowig, SM
    Avilés-Santa, ML
    Raskin, P
    [J]. DIABETES CARE, 2004, 27 (07) : 1577 - 1583
  • [50] Author’s response to “Is pramlintide a safe and effective adjunct therapy for patients with type 1 diabetes?”
    Louis Monnier
    [J]. Nature Clinical Practice Endocrinology & Metabolism, 2007, 3 (5): : E2 - E2
12345